Jane Straus

488 total citations
8 papers, 356 citations indexed

About

Jane Straus is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Jane Straus has authored 8 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Jane Straus's work include Prostate Cancer Treatment and Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jane Straus is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jane Straus collaborates with scholars based in United States, Spain and Slovenia. Jane Straus's co-authors include Glenn Liu, Mary Jane Staab, Douglas G. McNeel, Jens C. Eickhoff, Dona Alberti, George Wilding, Rebecca Marnocha, Edward J. Dunphy, Dorothea Horvath and Thomas Frye and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jane Straus

8 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Straus United States	7	232	182	145	111	34	8	356
Jason Cham United States	8	173 0.7×	272 1.5×	84 0.6×	61 0.5×	12 0.4×	20	355
Naoya Hida Japan	10	219 0.9×	237 1.3×	107 0.7×	152 1.4×	30 0.9×	34	402
Gareth Rivalland Australia	10	69 0.3×	112 0.6×	98 0.7×	78 0.7×	19 0.6×	26	248
Chengyan Zhang China	10	83 0.4×	153 0.8×	101 0.7×	144 1.3×	11 0.3×	24	346
E. Goode United Kingdom	7	86 0.4×	177 1.0×	106 0.7×	108 1.0×	25 0.7×	12	325
Aurélie Lagrange France	9	157 0.7×	267 1.5×	99 0.7×	103 0.9×	7 0.2×	22	387
Matilde Monti Italy	10	136 0.6×	212 1.2×	48 0.3×	69 0.6×	22 0.6×	13	365
Jinxi Zuo China	6	108 0.5×	97 0.5×	90 0.6×	108 1.0×	14 0.4×	10	350
Jesus C. Fabregas United States	8	54 0.2×	130 0.7×	47 0.3×	73 0.7×	23 0.7×	21	242
Giampiero Candeloro Italy	10	73 0.3×	171 0.9×	47 0.3×	67 0.6×	8 0.2×	33	333

Countries citing papers authored by Jane Straus

Since Specialization

Citations

This map shows the geographic impact of Jane Straus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Straus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Straus more than expected).

Fields of papers citing papers by Jane Straus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Straus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Straus. The network helps show where Jane Straus may publish in the future.

Co-authorship network of co-authors of Jane Straus

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Straus. A scholar is included among the top collaborators of Jane Straus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Straus. Jane Straus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Straus, Jane, et al.. (2018). Semen AMACR protein as a novel method for detecting prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(12). 532.e1–532.e7. 17 indexed citations

McNeel, Douglas G., Jens C. Eickhoff, Christopher D. Zahm, et al.. (2018). Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 9(39). 25586–25596. 61 indexed citations

McNeel, Douglas G., Jens C. Eickhoff, Robert Jeraj, et al.. (2017). DNA vaccine with pembrolizumab to elicit antitumor responses in patients with metastatic, castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(7_suppl). 168–168. 10 indexed citations

Simončič, Urban, Scott B. Perlman, Glenn Liu, et al.. (2014). Comparison of NaF and FDG PET/CT for Assessment of Treatment Response in Castration-Resistant Prostate Cancers With Osseous Metastases. Clinical Genitourinary Cancer. 13(1). e7–e17. 20 indexed citations

McNeel, Douglas G., Edward J. Dunphy, Thomas Frye, et al.. (2009). Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer. Journal of Clinical Oncology. 27(25). 4047–4054. 188 indexed citations

Attia, Steven, Jens C. Eickhoff, George Wilding, et al.. (2008). Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer. Clinical Cancer Research. 14(8). 2437–2443. 47 indexed citations

Dunphy, Edward J., Mary Jane Staab, Dorothea Horvath, et al.. (2007). Phase I study of a DNA-based vaccine targeting prostatic acid phosphatase (PAP) in patients with clinical stage D0 prostate cancer. Cancer Research. 67. 1858–1858. 1 indexed citations

Staab, Mary Jane, Jane Straus, Dona Alberti, et al.. (2005). A Phase I Study of a DNA Vaccine Targeting Prostatic Acid Phosphatase in Patients with Stage D0 Prostate Cancer. Clinical Genitourinary Cancer. 4(3). 215–218. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact